Table 2.
The rate of resistance to antibiotics related to surface adhesion genes
| Antibiotics | fimA (n = 30) | mrkA (n = 21) | pilQ (n = 46) | matB (n = 48) | p Value |
|---|---|---|---|---|---|
| CAZ | 16 (32%) | 9 (18%) | 16 (32%) | 16 (32%) | 0.212 |
| FEP | 12 (24%) | 7 (14%) | 12 (24%) | 12 (24%) | 0.104 |
| CTX | 15 (30%) | 6 (12%) | 16 (32%) | 15 (30%) | 0.132 |
| IPM | 4 (8%) | 3 (6%) | 4 (8%) | 4 (8%) | 0.195 |
| MEM | 3 (6%) | 3 (6%) | 4 (8%) | 5 (10%) | 0.191 |
| PITZ | 2 (4%) | 2 (4%) | 3 (6%) | 4 (8%) | 0.106 |
| FOX | 12 (24%) | 9 (18%) | 13 (26%) | 12 (24%) | 0.351 |
| AN | 2 (4%) | 1 (2%) | 3 (6%) | 3 (6%) | 0.011 |
| GN | 4 (8%) | 3 (6%) | 5 (10%) | 6 (12%) | 0.002 |
| CP | 10 (20%) | 11 (22%) | 5 (10%) | 12 (24%) | <0.001 |
| TE | 16 (32%) | 14 (28%) | 17 (34%) | 17 (34%) | 0.004 |
| SXT | 20 (40%) | 18 (39%) | 21 (42%) | 21 (42%) | 0.001 |
Abbreviations: CAZ, ceftazidime; FEP, cefepime; CTX, cefotaxime; IPM, imipenem; MEM, meropenem; PITZ, piperacillin-tazobactam; FOX, cefoxitin; AN, amikacin; GN, gentamicin; CP, ciprofloxacin; TE, tetracycline; SXT, tetracycline.